Inventor · disambiguated record
Charles Todd Eary
Also filed as: EARY CHARLES T · EARY CHARLES TODD
17 granted patents·5 pending applications·112 citations·filing 2001–2025
91Inventor score
Files withLOXO ONCOLOGY INC11ARRAY BIOPHARMA INC5DOHERTY GEORGE A1GRONEBERG ROBERT D1HALBROOK JAMES1
Top patents by PatentIndex Score
22 records- 0195US7179912B2Materials and methods to potentiate cancer treatmentLUITPOLD PHARM INC·Filed 2001·Granted Feb 20, 2007·79 cites·7 claims
- 0291US10786489B2Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2018·Granted Sep 29, 2020·9 cites·18 claims
- 0384US10745419B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2018·Granted Aug 18, 2020·2 cites·19 claims
- 0483US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 0581US11098064B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrileLOXO ONCOLOGY INC·Filed 2020·Granted Aug 24, 2021·1 cites·9 claims
- 0680US8304407B28-substituted benzoazepines as toll-like receptor modulatorsDOHERTY GEORGE A·Filed 2012·Granted Nov 6, 2012·5 cites·20 claims
- 0779US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 0878US12268666B2Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2024·Granted Apr 8, 2025·0 cites·8 claims
- 0978US12138250B2Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2022·Granted Nov 12, 2024·0 cites·13 claims
- 1077US11963950B2Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2021·Granted Apr 23, 2024·0 cites·23 claims
- 1171US12102621B2Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2020·Granted Oct 1, 2024·0 cites·16 claims
- 1269US11807651B2Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
- 1369US8404681B2Xanthones, thioxanthones and acridinones as DNA-PK inhibitorsHALBROOK JAMES W·Filed 2004·Granted Mar 26, 2013·7 cites·18 claims
- 1464US2025186400A1Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1562US12109193B2Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2019·Granted Oct 8, 2024·0 cites·6 claims
- 1653US8242115B2Materials and methods to potentiate cancer treatmentHALBROOK JAMES·Filed 2007·Granted Aug 14, 2012·0 cites·13 claims
- 1750US11091486B2Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereofARRAY BIOPHARMA INC·Filed 2017·Granted Aug 17, 2021·0 cites·11 claims
- 1850US2023322682A1Processes and intermediates for the preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1949US2019247398A1Formulations of a macrocyclic trk kinase inhibitorARRAY BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 2046US11214571B2Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereofARRAY BIOPHARMA INC·Filed 2017·Granted Jan 4, 2022·0 cites·16 claims
- 2146US2006270675A1Inhibitors of cholesterol ester transfer proteinGRONEBERG ROBERT D·Filed 2006·Application pending·0 cites
- 2235US2005282812A1Inhibitors of cholesteryl ester transfer proteinJONES Zachary·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →